The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 26, 2017
Filed:
Sep. 25, 2014
Applicant:
Pharmakea, Inc., San Diego, CA (US);
Inventors:
John Howard Hutchinson, San Diego, CA (US);
David Lonergan, San Marcos, CA (US);
Fei Huang, La Mesa, CA (US);
Martin Rowbottom, San Diego, CA (US);
Imelda Calderon, San Diego, CA (US);
Assignee:
PHARMAKEA, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/30 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 417/14 (2006.01); C07D 471/10 (2006.01); C07D 491/107 (2006.01); C07D 498/10 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 403/14 (2006.01); C07D 487/10 (2006.01); C07D 491/10 (2006.01); A61K 9/00 (2006.01); A61K 47/02 (2006.01); A61K 9/06 (2006.01); A61K 9/08 (2006.01); A61K 47/38 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
C07D 209/30 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61K 9/2054 (2013.01); A61K 9/4866 (2013.01); A61K 47/02 (2013.01); A61K 47/38 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/10 (2013.01); C07D 487/10 (2013.01); C07D 491/10 (2013.01); C07D 491/107 (2013.01); C07D 498/10 (2013.01);
Abstract
Described herein are compounds that are autotaxin inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with autotaxin activity.